Hematopoietic stem cell transplantation for autoimmune diseases: more than just prolonged immunosuppression

Current Opinion in Hematology
A Tyndall

Abstract

To summarize the current clinical experience in the use of autologous hematopoietic stem cell transplantation (HSCT) in autoimmune disease and to explore the concept of durable remission induction and tissue de-remodeling via restoration of normal niche function and "immune reset.' Controlled clinical trials in systemic sclerosis, multiple sclerosis, and Crohn's disease as well as extensive uncontrolled trial and registry data have established the unique role of HSCT in selected cases. Although HSCT for multiple sclerosis and systemic sclerosis has recently entered several official treatment guidelines, mechanistic studies are few but indicate some possible modes of action, for example, increase of regulatory T cells. Toxicity of HSCT remains high but is improving with protocol modifications and more precise patient selection. For the first time, it has been demonstrated that strategies exist which may permanently reprogram an autoaggressive immune system to one of self-tolerance independent of ongoing immunosuppression. In addition, some tissues have the capacity to repair damage via normal regenerative processes. The exact mechanism(s) as to how this is achieved in certain cases and not others are emerging. Such knowledge, to...Continue Reading

References

Apr 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·S IkeharaY Hamashima
Jan 1, 1994·Scandinavian Journal of Rheumatology. Supplement·T Pincus
Dec 31, 1997·The New England Journal of Medicine·R K BurtR Ramsey-Goldman
May 8, 1999·British Journal of Haematology·E D Thomas
Jul 14, 2004·Annals of the Rheumatic Diseases·D FargeUNKNOWN EBMT/EULAR Registry
Mar 15, 2005·Bone Marrow Transplantation·A GratwohlUNKNOWN Autoimmune Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
Jan 17, 2008·PloS One·Jo N FlemingStephen M Schwartz
Jan 14, 2009·Bone Marrow Transplantation·T DaikelerUNKNOWN Working Party Autoimmune Diseases of the EBMT
Jun 19, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Marcelo C PasquiniRichard A Nash
Dec 20, 2013·The New England Journal of Medicine·Lenny van BonTimothy R D J Radstake
Jul 25, 2014·JAMA : the Journal of the American Medical Association·Jacob M van LaarUNKNOWN EBMT/EULAR Scleroderma Study Group
Feb 13, 2015·Neurology·Giovanni L MancardiUNKNOWN ASTIMS Haemato-Neurological Collaborative Group On behalf of the Autoimmune Disease Working Party ADWP of the European Group
Dec 17, 2015·JAMA : the Journal of the American Medical Association·Christopher J HawkeyDominique Farge
Feb 24, 2017·Nature Reviews. Rheumatology·Joost F SwartNico M Wulffraat
Feb 28, 2017·JAMA Neurology·Paolo A MuraroUNKNOWN Multiple Sclerosis–Autologous Hematopoietic Stem Cell Transplantation (MS-AHSCT) Long-term Outcomes Study Group
Mar 28, 2017·Therapeutic Advances in Musculoskeletal Disease·Sara Guerreiro Castro, David A Isenberg
Jun 18, 2017·Nature Reviews. Neurology·Paolo A MuraroRiccardo Saccardi
Nov 21, 2017·Immunology Letters·Femke C C van Rhijn-BrouwerJacob M van Laar
Jan 4, 2018·The New England Journal of Medicine·Keith M SullivanUNKNOWN SCOT Study Investigators
Mar 9, 2018·Nature Reviews. Rheumatology·Richard K Burt, Dominique Farge

❮ Previous
Next ❯

Citations

Jul 16, 2019·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Alan Tyndall

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.